| Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury RL Mehta, JA Kellum, SV Shah, BA Molitoris, C Ronco, DG Warnock, ... Critical care 11, 1-8, 2007 | 9032 | 2007 |
| National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification AS Levey, J Coresh, E Balk, AT Kausz, A Levin, MW Steffes, RJ Hogg, ... Annals of internal medicine 139 (2), 137-147, 2003 | 5853 | 2003 |
| K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification AS Levey, J Coresh, K Bolton, B Culleton, KS Harvey, TA Ikizler, ... American Journal of Kidney Diseases 39 (2 SUPPL. 1), i-ii+ S1-S266, 2002 | 5597 | 2002 |
| Canagliflozin and renal outcomes in type 2 diabetes and nephropathy V Perkovic, MJ Jardine, B Neal, S Bompoint, HJL Heerspink, ... New England journal of medicine 380 (24), 2295-2306, 2019 | 5186 | 2019 |
| Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO) AS Levey, KU Eckardt, Y Tsukamoto, A Levin, J Coresh, J Rossert, ... Kidney international 67 (6), 2089-2100, 2005 | 5143 | 2005 |
| Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline PE Stevens, A Levin, ... Annals of internal medicine 158 (11), 825-830, 2013 | 3055 | 2013 |
| The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo … C Baigent, MJ Landray, C Reith, J Emberson, DC Wheeler, C Tomson, ... The Lancet 377 (9784), 2181-2192, 2011 | 2962 | 2011 |
| Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO) S Moe, T Drüeke, J Cunningham, W Goodman, K Martin, K Olgaard, S Ott, ... Kidney international 69 (11), 1945-1953, 2006 | 2296 | 2006 |
| Chronic kidney disease as a global public health problem: approaches and initiatives–a position statement from Kidney Disease Improving Global Outcomes AS Levey, R Atkins, J Coresh, EP Cohen, AJ Collins, KU Eckardt, ... Kidney international 72 (3), 247-259, 2007 | 2072 | 2007 |
| Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease A Levin, GL Bakris, M Molitch, M Smulders, J Tian, LA Williams, ... Kidney international 71 (1), 31-38, 2007 | 2022 | 2007 |
| Bone metabolism and disease in chronic kidney disease G Eknoyan, A Levin, NW Levin American Journal of Kidney Diseases 42, 1-201, 2003 | 1802 | 2003 |
| KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease G Eknoyan, N Lameire, K Eckardt, B Kasiske, D Wheeler, A Levin, ... Kidney int 3 (1), 5-14, 2013 | 1770 | 2013 |
| Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease A Levin, PE Stevens, RW Bilous, J Coresh, ALM De Francisco, ... Kidney international supplements 3 (1), 1-150, 2013 | 1603 | 2013 |
| Evolving importance of kidney disease: from subspecialty to global health burden KU Eckardt, J Coresh, O Devuyst, RJ Johnson, A Köttgen, AS Levey, ... The Lancet 382 (9887), 158-169, 2013 | 1344 | 2013 |
| Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin A Levin, CR Thompson, J Ethier, EJF Carlisle, S Tobe, D Mendelssohn, ... American Journal of Kidney Diseases 34 (1), 125-134, 1999 | 1320 | 1999 |
| A predictive model for progression of chronic kidney disease to kidney failure N Tangri, LA Stevens, J Griffith, H Tighiouart, O Djurdjev, D Naimark, ... Jama 305 (15), 1553-1559, 2011 | 1300 | 2011 |
| Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention A Levin, J Singer, CR Thompson, H Ross, M Lewis American Journal of Kidney Diseases 27 (3), 347-354, 1996 | 1067 | 1996 |
| Chronic kidney disease P Romagnani, G Remuzzi, R Glassock, A Levin, KJ Jager, M Tonelli, ... Nature reviews Disease primers 3 (1), 1-24, 2017 | 1048 | 2017 |
| Empagliflozin in patients with chronic kidney disease EMPA-Kidney Collaborative Group New England Journal of Medicine 388 (2), 117-127, 2023 | 979 | 2023 |
| National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation … RJ Hogg, S Furth, KV Lemley, R Portman, GJ Schwartz, J Coresh, E Balk, ... Pediatrics 111 (6), 1416-1421, 2003 | 970 | 2003 |
